|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.180 USD | -1.67% |
|
-0.76% | -49.32% |
| 07-27 | Spero Therapeutics, Inc. Announces Appointment of Debra Jeske Zack as Chief Medical Officer | CI |
| 07-15 | Innovent Biologics Shares Surge on Spero Deal That Could Be Worth $1.1 Billion | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.67% | -0.76% | -46.81% | -52.38% | -49.32% | -49.10% | -27.55% | -91.46% | - | 69.48M | |
| +2.35% | +0.77% | +3.15% | +17.23% | +41.69% | +29.92% | +85.38% | -14.38% | - | 55.23B | |
| -0.21% | -7.38% | -6.12% | +8.85% | +3.93% | +25.34% | +63.02% | +185.44% | +5,966.78% | 53.75B | |
| -2.46% | +1.78% | -3.19% | -6.79% | -4.50% | -15.42% | -16.49% | -73.28% | - | 23.48B | |
| -4.31% | -8.74% | -8.81% | -26.78% | -43.94% | -9.05% | +341.72% | +304.37% | +739.72% | 22B | |
| +2.49% | -1.27% | +11.97% | +17.25% | +23.22% | +15.99% | -10.53% | -67.31% | - | 19.78B | |
| +0.79% | -1.06% | +3.25% | +9.71% | -8.31% | +29.29% | -33.32% | -34.77% | +52.59% | 17.44B | |
| +0.58% | -7.23% | +10.91% | +3.07% | +23.36% | +24.50% | +519.07% | - | - | 14.66B | |
| -4.62% | -3.68% | -1.17% | +22.09% | +21.67% | +47.24% | +170.57% | +209.52% | +475.30% | 14.07B | |
| +3.41% | -7.83% | -12.25% | +77.89% | +150.18% | +161.76% | +284.91% | +1,349.84% | +609.16% | 13.02B | |
| -6.23% | -14.84% | -9.86% | -9.74% | -20.38% | +53.28% | +125.85% | +427.39% | +6,629.75% | 11.37B | |
| -2.71% | -0.28% | +6.12% | +14.10% | +28.57% | +440.25% | +147.28% | +25.51% | +1,356.66% | 12.3B | |
| +0.80% | -8.61% | +6.70% | -30.82% | -16.86% | -38.51% | +118.74% | +82.25% | - | 10.95B | |
| -2.87% | -3.33% | -8.46% | +23.20% | +22.84% | +107.36% | +134.03% | +171.29% | +579.29% | 10.92B | |
| -2.49% | -3.88% | -8.69% | -18.52% | -24.93% | -50.21% | +525.24% | +69.42% | +97.44% | 10.72B | |
| +0.17% | +0.07% | +116.61% | +114.72% | +79.99% | +193.06% | +340.97% | +378.22% | - | 8.82B | |
| -3.77% | -3.88% | +10.43% | +41.41% | +199.65% | +478.46% | +594.85% | -36.15% | -17.68% | 8.93B | |
| +2.96% | -6.36% | +10.03% | -18.74% | +13.54% | +26.35% | +72.47% | -17.63% | - | 7.93B | |
| -3.77% | -10.73% | +1.83% | +20.09% | +6.77% | +13.22% | +297.28% | +312.16% | - | 7.69B | |
| -3.61% | -1.09% | -3.59% | -5.03% | +17.18% | +59.25% | +12.49% | +140.50% | - | 8.08B | |
| Average | -1.26% | -3.01% | +3.60% | +10.04% | +23.22% | +77.15% | +187.30% | +174.79% | +1,648.90% | 16.56B | |
| Weighted average by Cap. | -0.62% | -1.13% | +2.68% | +11.12% | +21.31% | +58.58% | +154.21% | +151.07% | +2,589.01% |
- Stock Market
- Stocks
- SPRO Stock
- Sector Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
